COLLPLANT BIOTECHNOLOGIES LTD

NASDAQ: CLGN (CollPlant Biotechnologies Ltd.)

Kemas kini terakhir: 08 Mar, 12:53AM

3.34

0.20 (6.34%)

  • 1H 6.34%
  • 5H 83.46%
  • 1B 51.09%
  • 6B -25.47%
  • Tahun Ke Tarikh -12.36%
  • 1T -43.88%
  • 5T -66.00%
Penutupan Terdahulu 3.14
Buka 3.36
Jumlah Dagangan 2,155
Purata Dagangan (3B) 8,808
Modal Pasaran 38,246,576
Harga / Jualan (P/S) 47.82
Harga / Buku (P/B) 1.83
Julat 52 Minggu
3.00 (-10%) — 6.75 (102%)
Tarikh Pendapatan 2 Apr 2025 - 7 Apr 2025
Margin Operasi (TTM) -2,423.17%
EPS Cair (TTM) -1.45
Pertumbuhan Hasil Suku Tahunan (YOY) -45.20%
Jumlah Hutang/Ekuiti (D/E MRQ) 22.88%
Nisbah Semasa (MRQ) 4.44
Aliran Tunai Operasi (OCF TTM) -14.09 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -8.89 M
Pulangan Atas Aset (ROA TTM) -40.81%
Pulangan Atas Ekuiti (ROE TTM) -79.46%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Biotechnology (US) Menurun Menurun
Biotechnology (Global) Menurun Menurun
Stok CollPlant Biotechnologies Ltd. Menurun Menaik

AISkor Stockmoo

-0.1
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal 2.5
Osilator Teknikal -2.5
Purata -0.13

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
CLGN 38 M - - 1.83
GHRS 686 M - - 2.25
VIR 644 M - - 0.610
REPL 644 M - - 1.55
ZVRA 473 M - - 9.93
CGEM 461 M - - 0.840

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Sektor Healthcare
Industri Biotechnology
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 10.16%
% Dimiliki oleh Institusi 12.23%
17.4617.4615.7015.7013.9413.9412.1812.1810.4110.41Harga Sasaran MedianQ1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25
Julat 52 Minggu
3.00 (-10%) — 6.75 (102%)
Median 12.00 (259.39%)
Jumlah 1 Beli
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
D. Boral Capital 28 May 2025 12.00 (259.39%) Beli 0.000
27 Mar 2025 14.00 (319.29%) Beli 2.65

Tiada data dalam julat masa ini.

2.052.051.871.871.691.691.501.501.321.32May 7May 7May 8May 8May 9May 9May 12May 12May 13May 13May 14May 14May 15May 15May 16May 16

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
0.1000.100-0.000-0.000-0.100-0.100-0.200-0.200-0.300-0.300MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda